1. Naqvi R (2021) Epidemiological trends in community acquired acute Kidney Injury in Pakistan: 25 years Experience from a Tertiary Care Renal Unit. Pakistan journal of medical sciences 37:312-319. doi: 10.12669/pjms.37.2.3876
2. Hsu CY (2012) Yes, AKI truly leads to CKD. J Am Soc Nephrol 23:967-9. doi: 10.1681/ASN.2012030222
3. Chawla LS and Kimmel PL (2012) Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int 82:516-24. doi: 10.1038/ki.2012.208
4. Coca SG, Singanamala S and Parikh CR (2012) Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 81:442-8. doi: 10.1038/ki.2011.379
5. Chawla LS, Eggers PW, Star RA and Kimmel PL (2014) Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371:58-66. doi: 10.1056/NEJMra1214243
6. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA and Collins AJ (2009) Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 20:223-8. doi: 10.1681/ASN.2007080837
7. Sethi JK and Vidal-Puig A (2010) Wnt signalling and the control of cellular metabolism. Biochem J 427:1-17. doi: 10.1042/BJ20091866
8. Lim X and Nusse R (2013) Wnt signaling in skin development, homeostasis, and disease. Cold Spring Harb Perspect Biol 5. doi: 10.1101/cshperspect.a008029
9. He W, Dai C, Li Y, Zeng G, Monga SP and Liu Y (2009) Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 20:765-76. doi: 10.1681/ASN.2008060566
10. Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB and Liu Y (2009) Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 20:1997-2008. doi: 10.1681/ASN.2009010019
11. He L, Livingston MJ and Dong Z (2014) Autophagy in acute kidney injury and repair. Nephron Clin Pract 127:56-60. doi: 10.1159/000363677
12. Huang H and He X (2008) Wnt/beta-catenin signaling: new (and old) players and new insights. Curr Opin Cell Biol 20:119-25. doi: 10.1016/j.ceb.2008.01.009
13. van Kappel EC and Maurice MM (2017) Molecular regulation and pharmacological targeting of the beta-catenin destruction complex. Br J Pharmacol 174:4575-4588. doi: 10.1111/bph.13922
14. MacDonald BT, Tamai K and He X (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17:9-26. doi: 10.1016/j.devcel.2009.06.016
15. Hwang I, Seo EY and Ha H (2009) Wnt/beta-catenin signaling: a novel target for therapeutic intervention of fibrotic kidney disease. Arch Pharm Res 32:1653-62. doi: 10.1007/s12272-009-2200-3
16. Liu Y (2002) Hepatocyte growth factor and the kidney. Current Opinion in Nephrology and Hypertension 11:23-30. doi: 10.1097/00041552-200201000-00004.
17. Liu Y (2004) Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. American Journal of Physiology-Renal Physiology 287:F7-F16. doi: 10.1152/ajprenal.00451.2003
18. Zhou D, Fu H, Xiao L, Mo H, Zhuo H, Tian X, Lin L, Xing J and Liu Y (2018) Fibroblast-Specific beta-Catenin Signaling Dictates the Outcome of AKI. J Am Soc Nephrol 29:1257-1271. doi: 10.1681/ASN.2017080903
19. Marenholz I and Heizmann CW (2004) S100A16, a ubiquitously expressed EF-hand protein which is up-regulated in tumors. Biochemical and biophysical research communications 313:237-244. doi: 10.1016/j.bbrc.2003.11.115
20. Heizmann CW (2002) S100 proteins structure functions and pathology. Frontiers in Bioscience 7:d1356-1368. doi: 10.2741/a846
21. Yao R, Lopez-Beltran A, Maclennan GT, Montironi R, Eble JN and Cheng L (2007) Expression of S100 Protein Family Members in the Pathogenesis of Bladder Tumors. Anticancer Research 27:3051-3058.
22. Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ and Geczy CL (2013) Functions of S100 proteins. Curr Mol Med 13:24-57.
23. Saito K, Kobayashi M, Nagashio R, Ryuge S, Katono K, Nakashima H, Tsuchiya B, Jiang S-X, Saegusa M, Satoh Y, Masuda N and Sato Y (2015) S100A16 is a Prognostic Marker for Lung Adenocarcinomas. Asian Pacific journal of cancer prevention: APJCP 16:7039-7044. doi: 10.7314/APJCP.2015.16.16.7039
24. Zhu W, Xue Y, Liang C, Zhang R, Zhang Z, Li H, Su D, Liang X, Zhang Y, Huang Q, Liu M, Li L, Li D, Zhao AZ and Liu Y (2016) S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer. Tumour Biol 37:12241-12250. doi: 10.1007/s13277-016-5096-9
25. Liu Y, Zhang R, Xin J, Sun Y, Li J, Wei D and Zhao AZ (2011) Identification of S100A16 as a Novel Adipogenesis Promoting Factor in 3T3-L1 Cells. Endocrinology 152:903-911. doi: 10.1210/en.2010-1059
26. Sun H, Zhao A, Li M, Dong H, Sun Y, Zhang X, Zhu Q, Bukhari AA, Cao C, Su D, Liu Y and Liang X (2020) Interaction of calcium binding protein S100A16 with myosin-9 promotes cytoskeleton reorganization in renal tubulointerstitial fibrosis. Cell Death Dis 11:146. doi: 10.1038/s41419-020-2337-z
27. Yan C, Xu W, Huang Y, Li M, Shen Y, You H and Liang X (2016) HRD1-Mediated IGF-1R Ubiquitination Contributes to Renal Protection of Resveratrol in db/db Mice. Molecular endocrinology (Baltimore, Md.) 30:600-613. doi: 10.1210/me.2015-1277
28. Ferenbach DA and Bonventre JV (2015) Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nature Reviews Nephrology 11:264-276. doi: 10.1038/nrneph.2015.3
29. Wink DA and Mitchell JB (1998) Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radical Biology and Medicine 25:434-456. doi: 10.1016/s0891-5849(98)00092-6.
30. Shu S, Wang Y, Zheng M, Liu Z, Cai J, Tang C and Dong Z (2019) Hypoxia and Hypoxia-Inducible Factors in Kidney Injury and Repair. Cells 8:207. doi: 10.3390/cells8030207
31. Zhou D, Tan RJ, Fu H and Liu Y (2016) Wnt/β-catenin signaling in kidney injury and repair: a double-edged sword. Laboratory Investigation 96:156-167. doi: 10.1038/labinvest.2015.153
32. Xiao L, Zhou D, Tan RJ, Fu H, Zhou L, Hou FF and Liu Y (2016) Sustained Activation of Wnt/β-Catenin Signaling Drives AKI to CKD Progression. Journal of the American Society of Nephrology 27:1727-1740. doi: 10.1681/asn.2015040449
33. Giannopoulou M, Dai C, Tan X, Wen X, Michalopoulos GK and Liu Y (2008) Hepatocyte Growth Factor Exerts Its Anti-Inflammatory Action by Disrupting Nuclear Factor-κB Signaling. The American Journal of Pathology 173:30-41. doi: 10.2353/ajpath.2008.070583.
34. Gong R, Rifai A, Ge Y, Chen S and Dworkin LD (2008) Hepatocyte Growth Factor Suppresses Proinflammatory NFκB Activation through GSK3β Inactivation in Renal Tubular Epithelial Cells. Journal of Biological Chemistry 283:7401-7410. doi: 10.1074/jbc.M710396200.
35. Sturchler E, Cox JA, Durussel I, Weibel M and Heizmann CW (2006) S100A16, a Novel Calcium-binding Protein of the EF-hand Superfamily. Journal of Biological Chemistry 281:38905-38917. doi: 10.1074/jbc.M605798200.
36. Cong Y, Cui Y, Wang S, Jiang L, Cao J, Zhu S, Birkin E, Lane J, Ruge F, Jiang WG and Qiao G (2020) Calcium-Binding Protein S100P Promotes Tumor Progression but Enhances Chemosensitivity in Breast Cancer. Frontiers in oncology 10:566302-566302. doi: 10.3389/fonc.2020.566302
37. Li Y, Chen B, Yang X, Zhang C, Jiao Y, Li P, Liu Y, Li Z, Qiao B, Lau WB, Ma X-l and Du J (2019) S100a8/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic/Reperfusion Injury. Circulation 140:751-764. doi: 10.1161/CIRCULATIONAHA.118.039262
38. van den Bosch MH, Blom AB, Schelbergen RFP, Vogl T, Roth JP, Slöetjes AW, van den Berg WB, van der Kraan PM and van Lent PLEM (2016) Induction of Canonical Wnt Signaling by the Alarmins S100A8/A9 in Murine Knee Joints: Implications for Osteoarthritis. Arthritis & Rheumatology 68:152-163. doi: 10.1002/art.39420.
39. Dahlmann M, Kobelt D, Walther W, Mudduluru G and Stein U (2016) S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis Restriction. Cancers 8:59. doi: 10.3390/cancers8060059.
40. Moravkova P, Kohoutova D, Rejchrt S, Cyrany J and Bures J (2016) Role of S100 Proteins in Colorectal Carcinogenesis. Gastroenterol Res Pract 2016:2632703. doi: 10.1155/2016/2632703
41. Sapkota D, Bruland O, Parajuli H, Osman TA, Teh M-T, Johannessen AC and Costea DE (2015) S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma. BMC Cancer 15:631. doi: 10.1186/s12885-015-1622-1
42. Tanaka M, Ichikawa-Tomikawa N, Shishito N, Nishiura K, Miura T, Hozumi A, Chiba H, Yoshida S, Ohtake T and Sugino T (2015) Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion. BMC Cancer 15:53. doi: 10.1186/s12885-015-1059-6
43. Li D, Zhang R, Zhu W, Xue Y, Zhang Y, Huang Q, Liu M and Liu Y (2013) S100A16 inhibits osteogenesis but stimulates adipogenesis. Mol Biol Rep 40:3465-73. doi: 10.1007/s11033-012-2413-2
44. Chitalia V, Shivanna S, Martorell J, Meyer R, Edelman E and Rahimi N (2013) c-Cbl, a ubiquitin E3 ligase that targets active β-catenin: a novel layer of Wnt signaling regulation. The Journal of biological chemistry 288:23505-23517. doi: 10.1074/jbc.M113.473801
45. Valenta T, Hausmann G and Basler K (2012) The many faces and functions of β-catenin. The EMBO Journal 31:2714-2736. doi: 10.1038/emboj.2012.150.
46. Wu G, Huang H, Garcia Abreu J and He X (2009) Inhibition of GSK3 phosphorylation of beta-catenin via phosphorylated PPPSPXS motifs of Wnt coreceptor LRP6. PLoS One 4:e4926. doi: 10.1371/journal.pone.0004926
47. Liu W, Tang X, Qi X, Fu X, Ghimire S, Ma R, Li S, Zhang N and Si H (2020) The Ubiquitin Conjugating Enzyme: An Important Ubiquitin Transfer Platform in Ubiquitin-Proteasome System. International journal of molecular sciences 21:2894. doi: 10.3390/ijms21082894
48. Kny M, Standera S, Hartmann-Petersen R, Kloetzel P-M and Seeger M (2011) Herp regulates Hrd1-mediated ubiquitylation in a ubiquitin-like domain-dependent manner. The Journal of biological chemistry 286:5151-5156. doi: 10.1074/jbc.M110.134551